Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Phase 1/2a, Open-Label, Dose Finding and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sonrotoclax (BGB-11417) in Combination With Other Agents in Pediatric Patients Aged 6 Months to 17 Years, With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia
Authors not listed
BeOne Medicines · 2026
Abstract
The goal of this clinical trial is to learn if sonrotoclax (BGB-11417) is safe and may help treat children and adolescents with acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) that has come back after treatment or has not responded to treatment. The study will also learn how the body processes sonrotoclax when it is given with other medicines. The main questions it aims to answer are:
* Is sonrotoclax safe and well tolerated when given with other anti-cancer medicines?
* How does the body absorb, process, and remove sonrotoclax?
* Does treatment with sonrotoclax, in combination with other medicines, help reduce or eliminate leukemia?
Researchers will give sonrotoclax together with other anti-cancer medicines to participants with relapsed or refractory AML or ALL. Participants will:
* Take sonrotoclax in combination with other anti-cancer medicines
* Have regular clinic visits for physical exams, blood tests, heart monitoring, and other safety assessments.
* Provide blood samples to measure how the body processes sonrotoclax.
* Have tests to evaluate how their leukemia responds to treatment.
* Continue treatment as long as it is helping and side effects remain manageable, according to the study plan.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Anonymous. (2026). A Phase 1/2a, Open-Label, Dose Finding and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sonrotoclax (BGB-11417) in Combination With Other Agents in Pediatric Patients Aged 6 Months to 17 Years, With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia. <em>BeOne Medicines</em>. https://clinicaltrials.gov/study/NCT07770698
Vancouver
Anonymous. A Phase 1/2a, Open-Label, Dose Finding and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sonrotoclax (BGB-11417) in Combination With Other Agents in Pediatric Patients Aged 6 Months to 17 Years, With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia. BeOne Medicines. 2026.
BibTeX
@misc{anon2026APhase,
title = {A Phase 1/2a, Open-Label, Dose Finding and Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of Sonrotoclax (BGB-11417) in Combination With Other Agents in Pediatric Patients Aged 6 Months to 17 Years, With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia},
author = {Anonymous},
journal = {BeOne Medicines},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
University of Alabama, Tuscaloosa 2026
Open access · US-GOV
The Impact of BBTI on Cognition and Sleep Health in Older Adults With HIV
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2026
Open access · US-GOV
A Single-Center, Prospective, Single-Arm Clinical Study Evaluating the Efficacy and Safety of Thiotepa, Busulfan, and Fludarabine (TBF) Conditioning Regimen in Haploidentical Peripheral Blood Stem Cell Transplantation for Elderly Acute Myeloid Leukemia Patients in First Complete Remission
Manchester Metropolitan University 2026
Open access · US-GOV
Surveying the Dietary Intake, Physical Activity Patterns, Muscle Strength and Morphology of Adults With Inclusion Body Myositis
University of Chicago 2023
Open access · US-GOV
Investigating The Prognostic Significance Of Malnutrition And Sarcopenia In Older Adults With Acute Myeloid Leukemia
University of Illinois at Chicago 2014
Open access · US-GOV
Racial and Aging Effects of Acute Antioxidant Supplementation
Free Radical Biology and Medicine 2000
Citation only